AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
22 Apr 2003 04:47 PM
RNS
Capital Group
02 Apr 2003 03:51 PM
RNS
Exanta
01 Apr 2003 07:00 AM
RNS
Nexium
01 Apr 2003 07:00 AM
RNS
Purchase of Own Securities
31 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
26 Mar 2003 04:00 PM
RNS
Director Shareholding
13 Mar 2003 07:13 AM
RNS
Purchase of Own Securities
11 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
10 Mar 2003 07:00 AM
RNS
Crestor MRP Completion
10 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
07 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
05 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
03 Mar 2003 07:00 AM
RNS
Crestor in Europe
03 Mar 2003 07:00 AM
RNS
Purchase of Own Securities
27 Feb 2003 12:21 PM
RNS
Annual Report and Accounts
26 Feb 2003 07:00 AM
RNS
Purchase of Own Securities
19 Feb 2003 07:00 AM
RNS
Crestor
18 Feb 2003 07:00 AM
RNS
Research Update: AZD3582
17 Feb 2003 07:00 AM
RNS
Exanta Sportif
13 Feb 2003 07:01 AM
RNS
Crestor
11 Feb 2003 09:00 AM
RNS
Iressa
30 Jan 2003 11:00 AM
RNS
Final Results (part 2 of 2)
30 Jan 2003 11:00 AM
RNS
Final Results (part 1 of 2)
29 Jan 2003 09:00 AM
RNS
Notice of Results
14 Jan 2003 04:00 PM
RNS
Capital Group
10 Jan 2003 03:00 PM
RNS
Capital Group
09 Jan 2003 03:00 PM
RNS
Update on Iressa
02 Jan 2003 01:30 PM
RNS
Seroquel
23 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
20 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
19 Dec 2002 07:09 AM
RNS
Casodex
19 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
16 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
13 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
12 Dec 2002 10:00 AM
RNS
Omeprazole Judgment
12 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
11 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
06 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
05 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
04 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
02 Dec 2002 07:00 AM
RNS
Purchase of Own Securities
29 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
28 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
27 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
26 Nov 2002 04:07 PM
RNS
Director Shareholding
26 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
25 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
22 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
21 Nov 2002 07:00 AM
RNS
Purchase of Own Securities
18 Nov 2002 07:00 AM
RNS
Purchase of Own Securities

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings